http://orcid.org/0000-0002-1336-1724
References
- Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366(9501):1965–1976. doi: 10.1016/S0140-6736(05)67789-6
- Ramirez F, Carta L, Lee-Arteaga S, et al. Fibrillin-rich microfibrils – structural and instructive determinants of mammalian development and physiology. Connect Tissue Res. 2008;49(1):1–6. doi: 10.1080/03008200701820708
- Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–485. doi: 10.1136/jmg.2009.072785
- Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. doi: 10.1016/S0140-6736(15)00241-X
- Jha VN, Kumar M, Tarwani J. Co-occurrence of Marfan syndrome and bipolar disorder: a fifteen year follow up. Asian J Psychiatr. 2016;24:91–92. doi: 10.1016/j.ajp.2016.09.009
- Munkholm K, Braüner JV, Kessing LV, et al. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013;47(9):1119–1133. doi: 10.1016/j.jpsychires.2013.05.018
- Kalkman HO. Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia. Pharmacol Ther. 2009;121(1):115–122. doi: 10.1016/j.pharmthera.2008.11.002
- Numata S, Ueno SI, Iga JI, et al. Tgfbr2 gene expression and genetic association with schizophrenia. J Psychiatr Res. 2008;42(6):425–432. doi: 10.1016/j.jpsychires.2007.04.002
- Lichtenstein P, Yip BH, Björk C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373(9659):234–239. doi: 10.1016/S0140-6736(09)60072-6
- Drago A, Crisafulli C, Sidoti A, et al. The microtubule-associated molecular pathways may be genetically disrupted in patients with bipolar disorder. Insights from the molecular cascades. J Affect Disord. 2016;190:429–438. doi: 10.1016/j.jad.2015.10.016
- Djurovic S, Gustafsson O, Mattingsdal M, et al. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord. 2010;126(1):312–316. doi: 10.1016/j.jad.2010.04.007
- Bezchlibnyk YB, Wang JF, McQueen GM, et al. Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem. 2001;79(4):826–834. doi: 10.1046/j.1471-4159.2001.00628.x
- Kim YK, Myint AM, Lee BH, et al. T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatry Res. 2004;129(3):267–272. doi: 10.1016/j.psychres.2004.08.005
- Fiedorowicz JG, Prossin AR, Johnson CP, et al. Peripheral inflammation during abnormal mood states in bipolar I disorder. J Affect Disord. 2015;187:172–178. doi: 10.1016/j.jad.2015.08.036
- Li H, Hong W, Zhang C, et al. IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. J Affect Disord. 2015;174:361–366. doi: 10.1016/j.jad.2014.12.033